Total investments received (USD): 2.87m
Round value (USD): 1.16m
Round investors:
Bpifrance
Medin Fund Management
Company: BiPER Therapeutics
Industry:
Biotech
Health services




Belgium
Netherlands
Austria
Germany
Switzerland
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
Ireland
Italy
Portugal
Spain
United Kingdom